Kenya reports temporary disruption in Rotavirus vaccine supply

The Ministry of Health has announced a temporary disruption in the global supply of the Rotavac Frozen Rotavirus Vaccine, which is routinely administered to infants at six, ten and fourteen weeks of age. In a press statement, Health Cabinet Secretary Aden Duale said Kenya had bee..

✨ Key Highlights

Kenya is experiencing a temporary disruption in the supply of the Rotavac Frozen Rotavirus Vaccine, administered to infants during routine immunisation. The Ministry of Health announced the shortage, attributing it to production delays by the manufacturer, Bharat Biotech.

Kenya has approximately 4,000 doses remaining, less than a month's supply, with expected deliveries delayed until late April 2026.
The shortage is due to production delays at Bharat Biotech, announced by Gavi, the Vaccine Alliance, and expected to impact several countries during the 2026–2027 period.
Health Cabinet Secretary Aden Duale assured the public that the Ministry is working with UNICEF and partners to manage available stock and minimize disruption, urging continued attendance at immunisation appointments and reinforced diarrhoea prevention methods.